Quality of reporting of randomized controlled trials of pharmacologic treatment of bipolar disorders: A systematic review

Journal of Clinical Psychiatry

Volumn 72, Issue 9, 2011, Pages 1214-1221

  Strech, Daniel ^a   Soltmann, Bettina ^b   Weikert, Beate ^b,c   Bauer, Michael ^b   Pfennig, Andrea ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c Agency for Quality in Medicine   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; BIPOLAR DISORDER; CHECKLIST; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; EFFECT SIZE; EVIDENCE BASED MEDICINE; HUMAN; MAJOR CLINICAL STUDY; NATIONAL HEALTH ORGANIZATION; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLISHING; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREND STUDY;

EID: 79955564994     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.10r06166yel     Document Type: Review

References (38)

1. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.0.1. 2008. www.cochrane-handbook.org/. Verified November 11, 2010.
2. Altman DG, Schulz KF, Moher D, et al; CONSORT GROUP (Consolidated Standards of Reporting Trials). The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134(8):663-694. PubMed (Pubitemid 32322245)
3. Jüni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ. 2001;323(7303):42-46. doi:10.136/bmj.323.7303.42 PubMed (Pubitemid 32682008)
4. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273(5):408-412. doi:10.101/jama.273.5. 408 PubMed
5. Dans AL, Dans LF, Guyatt GH, et al; Evidence-Based Medicine Working Group. Users' guides to the medical literature, XIV: how to decide on the applicability of clinical trial results to your patient. JAMA. 1998;279(7):545-549. doi:10.101/jama.279.7.545 PubMed (Pubitemid 28113435)
6. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med. 1988;318(26):1728-1733. doi:10.1056/NEJM19806303182605 PubMed
7. McHenry L. Ethical issues in psychopharmacology. J Med Ethics. 2006;32(7):405-410. doi:10.136/jme.205.013185 PubMed (Pubitemid 44080967)
8. Whittington CJ, Kendall T, Fonagy P, et al. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet. 2004;363(9418):1341-1345. PubMed
9. Turner EH, Matthews AM, Linardatos E, et al. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358(3):252-260. doi:10.1056/NEJMsa06579 PubMed
10. Melander H, Ahlqvist-Rastad J, Meijer G, et al. Evidence b(i)ased medicine-selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ. 2003;326(7400):1171-1173. doi:10.136/bmj.326.740.171 PubMed (Pubitemid 36649049)
11. Atkins D, Best D, Briss PA, et al; GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490. doi:10.136/bmj.328.7454.1490 PubMed
12. Moher D, Schulz KF, Altman DG; CONSORT Group (Consolidated Standards of Reporting Trials). The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med. 2001;134(8):657-662. PubMed (Pubitemid 32322244)
13. Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med. 2010;7(3):e1000251. doi:10.1371/journal.pmed.10251 PubMed
14. International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publications, 2008. www.icmje.org. Verified November 11, 2010.
15. Falagas ME, Grigori T, Ioannidou E. A systematic review of trends in the methodological quality of randomized controlled trials in various research fields. J Clin Epidemiol. 2009;62(3):227-231. PubMed
16. CONSORT Group. CONSORT: Transparent Reporting of Trials, 2009; www.consort-statement.org. Verified November 11, 2010.
17. Thornley B, Adams C. Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ. 1998;317(7167):1181-1184. PubMed (Pubitemid 28488506)
18. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1-12. doi:10.1016/0197-2456(95)0134-4 PubMed (Pubitemid 26120810)
19. Cipriani A, Malvini L, Furukawa TA, et al. Relationship between quality of reports of antidepressant randomized controlled trials and treatment estimates: systematic review, meta-analysis, and meta-regression analysis. J Clin Psychopharmacol. 2007;27(4):352-356. doi:10.1097/jcp.0b013e3180a9081f PubMed (Pubitemid 47075505)
20. Schulz KF, Grimes DA. Sample size calculations in randomised trials: mandatory and mystical. Lancet. 2005;365(9467):1348-1353. doi:10.1016/S0140- 6736(05)61034-3 PubMed
21. Han C, Kwak KP, Marks DM, et al. The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatry. Contemp Clin Trials. 2009;30(2):116-122. doi:10.1016/j.ct.208.1.04 PubMed
22. Merikangas KR, Akiskal HS, Angst J, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2007;64(5):543-552. doi:10.101/archpsyc.64.5. 543 PubMed (Pubitemid 46718287)
23. Pini S, De Queiroz V, Pagnin D, et al. Prevalence and burden of bipolar disorders in European countries. Eur Neuropsychopharmacol. 2005;15(4):425-434. doi:10.1016/j.euroneuro.205.04.01 PubMed (Pubitemid 40943546)
24. Waraich P, Goldner EM, Somers JM, et al. Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry. 2004;49(2):124-138. PubMed (Pubitemid 38387422)
25. Kupfer DJ, Frank E, Grochocinski VJ, et al. Demographic and clinical characteristics of individuals in a bipolar disorder case registry. J Clin Psychiatry. 2002;63(2):120-125. PubMed (Pubitemid 34173848)
26. Fajutrao L, Locklear J, Priaulx J, et al. A systematic review of the evidence of the burden of bipolar disorder in Europe. Clin Pract Epidemol Ment Health. 2009;5(1):3. doi:10.186/1745-0179-5-3
27. Pfennig A, Weikert B, Falkai P, et al. [Development of the evidence-based S3 Guideline for Diagnosis and Therapy of Bipolar Disorders] [article in German]. Nervenarzt. 2008;79(4):500-504. PubMed
28. National Institute for Health and Clinical Excellence. Bipolar Disorder: The Management of Bipolar Disorder in Adults, Children and Adolescents, in Primary and Secondary Care. National Clinical Practice Guideline Number 38. National Collaborating Centre for Mental Health, Commissioned by the National Institute for Health and Clinical Excellence (NICE). London, England: The British Psychological Society and Gaskell; 2006.
29. Huwiler-Müntener K, Jüni P, Junker C, et al. Quality of reporting of randomized trials as a measure of methodologic quality. JAMA. 2002;287(21):2801-2804. doi:10.101/jama.287.21.2801 PubMed (Pubitemid 34591968)
30. Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA. 2000;283(20):2701-2711. doi:10.101/jama.283.20.2701 PubMed (Pubitemid 30337334)
31. World Medical Association. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. Seoul, South Korea: World Medical Association; 2008.
32. Council for International Organizations of Medical Sciences. International Ethical Guidelines for Biomedical Research Involving Human Subjects. Geneva, Switzerland: Council for International Organizations of Medical Sciences; 2002.
33. Emanuel EJ, Wendler D, Grady C. An ethical framework for biomedical research. In: Emanuel EJ, Grady C, Crouch RA, et al, eds. The Oxford Textbook of Clinical Research Ethics. Oxford, England: Oxford University Press; 2008:123-135.
34. Sackett DL, Straus S, Scott Richardson W. Evidence-Based Medicine: How to Practice and Teach EBM. Philadelphia, PA: Churchill Livingstone; 2000.
35. Fletcher RW, Fletcher SW. Clinical Epidemiology: The Essentials. 4th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2005.
36. Chan AW, Hróbjartsson A, Haahr MT, et al. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA. 2004;291(20):2457-2465. doi:10.101/jama.291.20.2457 PubMed (Pubitemid 38669189)
37. Lexchin J, Bero LA, Djulbegovic B, et al. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ. 2003;326(7400):1167-1170. doi:10.136/bmj.326.740.167 PubMed (Pubitemid 36649048)
38. Dwan K, Altman DG, Arnaiz JA, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS ONE. 2008;3(8):e3081.